Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Liam on +441494 818 027 or liam@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Liam Whelan
Senior Account Manager
liam@zenopa.com
+441494 818 027

Testimonials
All credit to the Zenopa team who looked after me and got me the position and a wonderful car /expenses paid. They have been especially great as a contact - very personable and explained everything.
Angela, 2014

PerkinElmer sells off illumination and detection solutions unit

1 September 2010 00:00 in Scientific Company News


PerkinElmer is increasing its focus on the healthcare sector by selling off its illumination and detection solutions business unit.

The division, which supplies lighting, sensors, subsystems and integrated solutions to the health, environmental and security sectors, is being divested to Veritas Capital Fund III in exchange for $500 million (325 million pounds).

PerkinElmer explained that the sale of this business unit allows it to simplify its business strategy and enables greater investment in the human health and environmental health industries.

Robert Friel, chairman and chief executive officer of PerkinElmer, expressed confidence that the business will benefit from a reduced exposure to "more cyclical end markets".

He added: "Furthermore, we would expect adjusted gross margins to improve by over 200 basis points, contributing to higher earnings growth."

Earlier this month, the company reported satisfaction with its financial performance in the second quarter of the year after posting a 14 per cent year-on-year increase in revenue for the period.ADNFCR-8000103-ID-800047456-ADNFCR

Other news stories from 01/09/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd